Rheumatology Leaders to HHS: Prior Authorization, Recent Part B Payment Change are Biggest Threats to Healthcare Choice and Competition
American College of Rheumatology (ACR)The ACR urged HHS to reform its prior authorization policies, to reverse a recent HHS decision to apply Part B drug spending to payment adjustments under the Merit-Based Incentive Payment System (MIPS); require pharmacy benefit managers (PBMs) to be more transparent; and continue supporting biosimilar innovation.